One stock which has been recently hammered due to litigation against it by other pharma companies , is SUN PHARMA.

After falling from a level of 1850/- to near Rs 1500, we may presume that it is now over sold and is very near to a support level of Rs 1500. A corrective bounce back is likely towards Rs 1650/1700 levels.
One may consider buying it above Rs 1555 with stop placed at Rs 1500 for a target at Rs 1650 - 1700
As for other frontline stocks, the overall trend is down, hence use upmoves to exit longs if still holding.
Happy trading !
CA Rajiv D Khatlawala
www.investogyan.com
No comments:
Post a Comment